ClinicalTrials.gg
WithdrawnNCT02694250Updated Mar 4, 2020

Evaluation of Cervical Fusion With DTRAX® Cervical Cage With DTRAX Bone Screw

An interventional study of DTRAX® Cervical Cage with DTRAX Bone Screw in Cervical Radiculopathy, sponsored by Providence Medical Technology, Inc.. Withdrawn at 7 sites in United States. Open to participants aged 35 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-03-04.

Sponsored by Providence Medical Technology, Inc. · Not applicable, Interventional, and Treatment

How we know

Why this study was withdrawn
study not started due to lack of resources

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
35 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 127 studies in Radiculopathy with a site in United States — 30 open to participants now, 38 under way, 2 of them phase 3. Radiculopathy · United States.

Enrollment
102nd of 106
0 · median 78
Started
2015
with 3 others
No phase
63 of 127
17 open now
Registered
54th of 127
by date
Lead sponsor
5 of 127
Providence Medical Technology, Inc.

Among the 127 studies in Radiculopathy with a site in United States, this one is the 102nd largest by enrollment of the 106 interventional ones that give a count, is one of 4 that started in 2015, is one of 63 with no phase, and was the 54th registered.

Radiculopathy

488 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

Browse Radiculopathy studies →

Open to participants now

30 of the 127 studies in Radiculopathy with a site in United States are open now. Recruiting first, the newest first:

25 more — sign in →

All 30 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 79 Radiculopathy studies recruiting now, 23 (29%) set no upper age limit and 48 (61%) stop at 75 or younger; 3 take children under 18; 7 take healthy volunteers.

This study: 35 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 127 studies in Radiculopathy with a site in United States, or all of them as a file.
02

Study summary

This study is being conducted to assess the radiographic (x-rays and CT scans) and clinical outcomes for the use of DTRAX Cervical Cage with DTRAX Bone Screw for the treatment of degenerative disc disease at one disc level with accompanying radicular symptoms in the cervical (neck) spine.

03

Conditions studied

  • Cervical Radiculopathy

Browse trials for

Keywords

  • cervical
  • fusion
  • radiculopathy
  • DTRAX
04

Who can participate

Ages eligible
35 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Subject diagnosed with one level cervical spondylosis with radiculopathy in C3-C7, defined as follows:

    a. Radiographically (at least one): i. degenerated disc on MRI and/or CT; ii. decreased disc height on MRI and/or CT; and/or iii. foraminal stenosis, as demonstrated by MRI and/or CT. b. Clinically: radicular symptoms (at least one): i. arm/shoulder pain; ii. decreased reflexes; iii. decreased strength; and/or iv. decreased sensation.

  2. Subject has dynamic stenosis relieved by traction and made worse by a Spurlings maneuver.
  3. Subject is 35-80 years of age, inclusive.
  4. Subject is unresponsive to 6 weeks conservative, nonoperative treatment, or clinically indicated sooner due to the presence of progressive symptoms or signs of nerve root in spite of combined nonoperative management.
  5. Preoperative Neck Disability Index (NDI) score of > 30.
  6. Preoperative Neck pain or Arm pain score of > 6 on Neck and Arm VAS Pain Scales.
  7. Subject is a male or non-pregnant, non-lactating female.
  8. Subject must have the ability to understand and voluntarily provide written, .
  9. Subject is able to meet the proposed follow-up schedule.
  10. Subject is able to follow the postoperative management program.

Exclusion criteria

Exclusion Criteria:

  1. Any previous cervical spinal surgery.
  2. Subject has known osteoporosis, osteomalacia, spinal , or metabolic bone disease OR subject has sustained a vertebral compression or nontraumatic hip or wrist fracture.
  3. Subject has overt or active spinal and/or systemic infection.
  4. Subject has cervical spondylolisthesis > 3.5mm or rotator subluxation.
  5. Subject has cervical myelopathy.
  6. Subject has a chronic pain syndrome.
  7. Subject has radicular findings with major motor impairment.
  8. Subject has a condition that requires postoperative medications that interfere with fusion or the stability of the implant, such as (ie. corticosteroids, methotrexate, immunosuppressives).
  9. Subject is mentally incompetent.
  10. Subject is a prisoner.
  11. Subject is pregnant.
  12. Subject abuses alcohol or drugs.
  13. Subject has a cervical spinal condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level.
  14. Subject has insulin dependent diabetes.
  15. Subject has chronic or acute renal failure or prior history of renal disease.
  16. Subject has documented allergy or intolerance to stainless steel, titanium, or a titanium alloy.
  17. Subject has or is planning to receive drugs which may interfere with bone metabolism within two weeks prior to or six months following the date of surgery.
  18. Subject has history of an endocrine or metabolic disorder known to affect osteogenesis.
  19. Subject has had treatment with an therapy within 28 days prior to surgery or such treatment is planned during the 16 weeks following implantation of DTRAX Cervical Cage with DTRAX Bone Screw.
  20. Subject is involved in or planning spinal litigation or Workmen's Compensation claim.
  21. Subject is morbidly obese, defined as (BMI) > 40.
  22. Subject has a medical condition or extenuating circumstance that, in the Investigator's opinion, would prevent the subject from complying with postoperative follow-up visits.
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Other
    DTRAX Cervical Cervical Cage with DTRAX Bone Screw

    Device: DTRAX® Cervical Cage with DTRAX Bone Screw

Interventions

  • DeviceDTRAX® Cervical Cage with DTRAX Bone Screw

    DTRAX Cervical Cage is an intervertebral fusion device that provides mechanical support to the spine. DTRAX Cervical Cage is intended to be used in cervical spine fusion surgery. DTRAX Bone Screw is indicated for use in arthrodesis and provides supplemental fixation. .

06

What researchers measure

Primary outcomes

  1. Assess the radiographic outcome data on fusion status, device retention, and maintenance of segmental lordosis at the index level utilizing DTRAX Cervical Cage with DTRAX Bone Screw used in the treatment of cervical radiculopathy

    Time frame: Baseline throughout 24 months post-operatively

Secondary outcomes

  1. Assess the clinical outcome data based Neck Disability Index (NDI)

    Time frame: Baseline throughout 24 months post-operatively

  2. Assess the clinical outcome data based SF-12 v2 Health Survey

    Time frame: Baseline throughout 24 months post-operatively

  3. Assess the clinical outcome data based the Visual Analogue Scale (Neck and Arm VAS)

    Time frame: Baseline throughout 24 months post-operatively

  4. Safety information will be evaluated by collecting the type, frequency, severity, and device and procedure-relatedness of adverse events

    Time frame: Baseline throughout 24 months post-operatively

07

Study locations

7 sites
  • Neurospine Institute Medical Group
    San Francisco, California 94115, United States
  • Daytona Orthopaedic and Spinal Research Group
    Daytona Beach, Florida 32117, United States
  • Foundation for Orthopaedic Research and Education
    Tampa, Florida 33637, United States
  • Louisiana State University Health Sciences Center - New Orleans (LSUHSC - NO)
    New Orleans, Louisiana 70112, United States
  • Upstate Orthopedics
    East Syracuse, New York 13057, United States
  • Southern New York NeuroSurgical Group, P.C.
    Johnson City, New York 13790, United States
  • Cary Orthopaedic Spine Specialists
    Cary, North Carolina 27518, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2015, a primary completion of Sep 2016 and a completion of Sep 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 15, 2016
First posted
Feb 29, 2016
Start
Nov 2015
Primary completionActual
Sep 2016
CompletionActual
Sep 2016
Last update
Mar 4, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02694250
Lead sponsor
Providence Medical Technology, Inc.
Responsible party
Sponsor
First posted
Feb 29, 2016
Start date
Nov 2015
Primary completion
Sep 2016
Completion
Sep 2016
Last update
Mar 4, 2020

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion